Mayo Clinic-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2015

  1. B7-H3 promotes pathogenesis of autoimmune disease and inflammation by regulating the activity of different T cell subsets

    PLoS ONE, Vol. 10, Núm. 6

2010

  1. Immunology and gene therapy: Shoulder to shoulder into the fray

    Molecular Therapy

2005

  1. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus

    Vaccine, Vol. 23, Núm. 27, pp. 3493-3499

2004

  1. Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens

    International Journal of Cancer, Vol. 110, Núm. 1, pp. 51-60

2001

  1. IL-12 gene therapy for cancer: In synergy with other immunotherapies

    Trends in Immunology, Vol. 22, Núm. 3, pp. 113-115

2000

  1. Feeding dendritic cells with tumor antigens: Self-service buffet or a la carte?

    Gene Therapy, Vol. 7, Núm. 14, pp. 1167-1170

1998

  1. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway

    European Journal of Immunology, Vol. 28, Núm. 3, pp. 1116-1121

  2. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies

    Cellular Immunology, Vol. 190, Núm. 2, pp. 167-172